Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Foell

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|March 9, 2019
Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up StudyNienke M Ter Haar, E H Pieter van Dijkhuizen, Joost F Swart, et al.
Arthritis Care & Research|December 17, 2013
Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritisFriederike Rothmund, Joachim Gerss, Nicolino Ruperto, et al.
Journal of Clinical Immunology|January 17, 2024
Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting TherapiesMarie-Christin Hoffmann, Giulio Cavalli, Natalie Fadle, et al.
Arthritis Research & Therapy|August 8, 2015
MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritisJanneke Anink, Lisette W A Van Suijlekom-Smit, Marieke H Otten, et al.
Medrxiv : the Preprint Server for Health Sciences|March 26, 2024
Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic ArthritisMariana Correia Marques, Danielle Rubin, Emily Shuldiner, et al.
Rheumatology (Oxford, England)|September 24, 2021
MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged feverCarolin Park, María Miranda-Garcia, Rainer Berendes, et al.
Arthritis Research & Therapy|October 26, 2016
S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritisEdwin J W Geven, Martijn H J van den Bosch, Irene Di Ceglie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2024
Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic ArthritisMariana Correia Marques, Danielle Rubin, Emily G Shuldiner, et al.
RMD Open|November 24, 2024
Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean feverInès Elhani, Stefan Backes, Tilmann Kallinich, et al.
Pediatric Rheumatology Online Journal|May 9, 2026
Speaking the same language: international cross-validation of emerging biomarkers for juvenile idiopathic arthritis and Still's DiseaseMichael G Matt, Sabrina Fuehner, Thuy Do, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Arthritis & Rheumatology (Hoboken, N.J.)|March 9, 2019
Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up StudyNienke M Ter Haar, E H Pieter van Dijkhuizen, Joost F Swart, et al.
Arthritis Care & Research|December 17, 2013
Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritisFriederike Rothmund, Joachim Gerss, Nicolino Ruperto, et al.
Journal of Clinical Immunology|January 17, 2024
Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting TherapiesMarie-Christin Hoffmann, Giulio Cavalli, Natalie Fadle, et al.
Arthritis Research & Therapy|August 8, 2015
MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritisJanneke Anink, Lisette W A Van Suijlekom-Smit, Marieke H Otten, et al.
Medrxiv : the Preprint Server for Health Sciences|March 26, 2024
Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic ArthritisMariana Correia Marques, Danielle Rubin, Emily Shuldiner, et al.
Rheumatology (Oxford, England)|September 24, 2021
MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged feverCarolin Park, María Miranda-Garcia, Rainer Berendes, et al.
Arthritis Research & Therapy|October 26, 2016
S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritisEdwin J W Geven, Martijn H J van den Bosch, Irene Di Ceglie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2024
Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic ArthritisMariana Correia Marques, Danielle Rubin, Emily G Shuldiner, et al.
RMD Open|November 24, 2024
Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean feverInès Elhani, Stefan Backes, Tilmann Kallinich, et al.
Pediatric Rheumatology Online Journal|May 9, 2026
Speaking the same language: international cross-validation of emerging biomarkers for juvenile idiopathic arthritis and Still's DiseaseMichael G Matt, Sabrina Fuehner, Thuy Do, et al.
Pageof 22